Conmed (CNMD) Tops Q3 EPS by 4c
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $43.45 +0.58%
Revenue Growth %: -1.4%
Financial Fact:
Research and development expense: 8.35M
Today's EPS Names:
PEBK, DIT, AMC, More
Revenue Growth %: -1.4%
Financial Fact:
Research and development expense: 8.35M
Today's EPS Names:
PEBK, DIT, AMC, More
Join SI Premium – FREE
Conmed (NASDAQ: CNMD) reported Q3 EPS of $0.80, $0.04 better than the analyst estimate of $0.76. Revenue for the quarter came in at $248.8 million versus the consensus estimate of $255.53 million.
GUIDANCE:
Conmed sees FY2021 EPS of $3.18-$3.23, versus the consensus of $3.19.
For earnings history and earnings-related data on Conmed (CNMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Calix, Inc. (CALX) Tops Q2 EPS by 6c, Offers Guidance
- Eagle Nuclear Energy reports Q2 2026 update with $28.1M cash
- Farmers & Merchants Bancorp (FMCB) Reports Q2 EPS of $36.39
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
